Squadron Capital Management LLC
Q2 2026 13F filing
Updated 27 days ago43 disclosed positions worth $322.2M
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | R RLMD RELMADA THERAPEUTICS INC | $50.9M | 7.35M | 15.78% | — |
| 2 | B BEPC C4 THERAPEUTICS INC | $33.6M | 7.20M | 10.43% | — |
| 3 | C COGT COGENT BIOSCIENCES INC | $33.5M | 865.0K | 10.39% | — |
| 4 | K KOD KODIAK SCIENCES INC | $19.5M | 500.0K | 6.05% | — |
| 5 | R RLAY RELAY THERAPEUTICS INC | $18.1M | 970.0K | 5.63% | — |
| 6 | ? N/A ZENTALIS PHARMACEUTICALS INC | $17.9M | 3.70M | 5.57% | — |
| 7 | E EWTX EDGEWISE THERAPEUTICS INC | $11.8M | 290.0K | 3.66% | — |
| 8 | M MAZE MAZE THERAPEUTICS INC | $10M | 335.0K | 3.10% | — |
| 9 | I IVEVF INVENTIVA SA | $9.2M | 2.44M | 2.86% | — |
| 10 | A ANL ADLAI NORTYE LTD | $8.8M | 764.9K | 2.73% | — |
| 11 | E ELVN ENLIVEN THERAPEUTICS INC | $8.1M | 160.0K | 2.52% | — |
| 12 | A AVBP ARRIVENT BIOPHARMA INC | $6.4M | 183.0K | 1.97% | — |
| 13 | ? N/A PALISADE BIO INC | $6.3M | 3.00M | 1.95% | — |
| 14 | ? N/A BIOAGE LABS INC | $6.1M | 250.0K | 1.90% | — |
| 15 | I IKT INHIBIKASE THERAPEUTICS INC | $6.1M | 3.00M | 1.89% | — |
| 16 | A ADAG ADAGENE INC | $5.3M | 1.25M | 1.63% | — |
| 17 | F FBRX FORTE BIOSCIENCES INC | $4.8M | 225.0K | 1.48% | — |
| 18 | R RZLT REZOLUTE INC | $4.7M | 900.0K | 1.45% | — |
| 19 | I IFRX INFLARX NV | $4.5M | 2.00M | 1.39% | — |
| 20 | A ASH ASSEMBLY BIOSCIENCES INC | $4.4M | 160.0K | 1.36% | — |
| 21 | C CMPS COMPASS PATHWAYS PLC | $4.3M | 305.0K | 1.34% | — |
| 22 | P PMN PROMIS NEUROSCIENCES INC | $4.3M | 325.0K | 1.33% | — |
| 23 | C CTNM CONTINEUM THERAPEUTICS INC | $4.3M | 260.0K | 1.32% | — |
| 24 | C CMPS COMPASS PATHWAYS PLC | $4.2M | 300.0K | 1.32% | — |
| 25 | D DFTX DEFINIUM THERAPEUTICS INC | $4M | 85.0K | 1.24% | — |
| 26 | S SLGL SOL-GEL TECHNOLOGIES LTD | $3.9M | 52.0K | 1.20% | — |
| 27 | ? N/A BIOAGE LABS INC | $3.8M | 155.0K | 1.18% | — |
| 28 | S SCYX SCYNEXIS INC | $3.1M | 756.9K | 0.96% | — |
| 29 | P PRQR PROQR THRAPEUTICS N V | $2.8M | 1.51M | 0.87% | — |
| 30 | I IRON DISC MEDICINE INC | $2.2M | 30.0K | 0.68% | — |
| 31 | R RZLT REZOLUTE INC | $2.1M | 403.4K | 0.65% | — |
| 32 | L LPCN LIPOCINE INC NEW | $2.1M | 810.0K | 0.64% | — |
| 33 | ? N/A ZENTALIS PHARMACEUTICALS INC | $2.1M | 426.0K | 0.64% | — |
| 34 | B BEPC C4 THERAPEUTICS INC | $1.9M | 400.0K | 0.58% | — |
| 35 | R RARE ULTRAGENYX PHARMACEUTICAL IN | $1.8M | 55.0K | 0.57% | — |
| 36 | ? N/A CUE BIOPHARMA INC | $1.6M | 50.0K | 0.49% | — |
| 37 | ? N/A CALCIMEDICA INC | $1.3M | 1.24M | 0.40% | — |
| 38 | ? N/A QUINCE THERAPEUTICS INC | $734K | 40.4K | 0.23% | — |
| 39 | ? N/A NUVECTIS PHARMA INC | $712K | 38.7K | 0.22% | — |
| 40 | K KTTAW PASITHEA THERAPEUTICS CORP | $515K | 1.00M | 0.16% | — |
| 41 | I INM INMED PHARMACEUTICALS INC | $504K | 325.0K | 0.16% | — |
| 42 | N NMRA NEUMORA THERAPEUTICS INC. | $170K | 100.0K | 0.05% | — |
| 43 | N NXTC NEXTCURE INC | $103K | 64.5K | 0.03% | — |